Ovid Therapeutics
OVID
OVID
91 hedge funds and large institutions have $144M invested in Ovid Therapeutics in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
+12
Holders Change %
+15.19%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
24
Increased
22
Reduced
29
Closed
12
Calls
$760K
Puts
$465K
Net Calls
+$295K
Net Calls Change
-$39K
Top Buyers
| 1 |
AG
Artal Group
Luxembourg
|
+$14.4M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$7.18M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$7.06M |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$6.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.72M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$18.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$4.98M |
| 3 |
Renaissance Technologies
New York
|
-$4.6M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.76M |
| 5 |
BlackRock
New York
|
-$886K |
